CCL2: A potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis

European Journal of Immunology

Volumn 41, Issue 12, 2011, Pages 3412-3418

  Ansari, Abdul W ^a   Heiken, Hans ^a   Meyer Olson, Dirk ^a   Schmidt, Reinhold E ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Anti inflammatory; CCL2; Chemokine; HIV 1; Pathogenesis

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR2A; CHEMOKINE RECEPTOR CCR2B; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; DNA POLYMORPHISM; DRUG TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; TH2 CELL; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CHEMOKINE CCL2; HIV-1; HUMANS; VIRUS REPLICATION;

EID: 82255186886     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141676     Document Type: Article

References (70)

1. Rollins, B. J., Chemokines. Blood 1997. 90: 909-928.
2. Moser, B. and Loetscher, P., Lymphocyte traffic control by chemokines. Nat. Immunol. 2001. 2: 123-128.
3. Van Coillie, E., Van Damme, J. and Opdenakker, G., The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev. 1999. 10: 61-86.
4. Ansari, A. W., Bhatnagar, N., Dittrich-Breiholz, O., Kracht, M., Schmidt, R. E. and Heiken, H., Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals. Int. Immunol. 2006. 18: 1443-1451.
5. Yoshimura, T., Robinson, E. A., Tanaka, S., Appella, E. and Leonard, E. J., Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J. Immunol. 1989. 142: 1956-1962.
6. Sorensen, T. L., Ransohoff, R. M., Strieter, R. M. and Sellebjerg, F., Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. Eur. J. Neurol. 2004. 11: 445-449.
7. Kusano, K. F., Nakamura, K., Kusano, H., Nishii, N., Banba, K., Ikeda, T., Hashimoto, K. et al., Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis. Circ. J. 2004. 68: 671-676.
8. Sartipy, P. and Loskutoff, D. J., Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 2003. 100: 7265-7270.
9. Hayashida, K., Nanki, T., Girschick, H., Yavuz, S., Ochi, T. and Lipsky, P. E., Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthritis Res. 2001. 3: 118-126.
10. Kawano, S. and Nakamachi, Y., miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis. Ann. Rheum. Dis. 2011 70, i88-i91.
11. Rafei, M., Berchiche, Y. A., Birman, E., Boivin, M. N., Young, Y. K., Wu, J. H., Heveker, N. et al., An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis. J. immunol. 2009. 183: 1759-1766.
12. Kulkarni, O., Eulberg, D., Selve, N., Zollner, S., Allam, R., Pawar, R. D., Pfeiffer, S. et al., Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice. J. Pharmacol. Exp. Ther. 2009. 328: 371-377.
13. Fridlender, Z. G., Buchlis, G., Kapoor, V., Cheng, G., Sun, J., Singhal, S., Crisanti, M. C. et al., CCL2 blockade augments cancer immunotherapy. Cancer Res. 2010. 70: 109-118.
14. Qian, B. Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A. et al., CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011. 475: 222-225.
15. Zhang, J., Lu, Y. and Pienta, K. J., Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth. J. Natl. Cancer Inst. 2010. 102: 522-528.
16. Gu, L., Tseng, S., Horner, R. M., Tam, C., Loda, M. and Rollins, B. J., Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000. 404: 407-411.
17. Otero, K., Vecchi, A., Hirsch, E., Kearley, J., Vermi, W., Del Prete, A., Gonzalvo-Feo, S. et al., Nonredundant role of CCRL2 in lung dendritic cell trafficking. Blood 116: 2942-2949.
18. Mantovani, A., The chemokine system: redundancy for robust outputs. Immunol. Today 1999. 20: 254-257.
19. Charo, I. F., Myers, S. J., Herman, A., Franci, C., Connolly, A. J. and Coughlin, S. R., Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. USA 1994. 91: 2752-2756.
20. Bartoli, C., Civatte, M., Pellissier, J. F. and Figarella-Branger, D., CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies. Acta Neuropathol. 2001. 102: 385-392.
21. Cho, M. L., Yoon, B. Y., Ju, J. H., Jung, Y. O., Jhun, J. Y., Park, M. K., Park, S. H. et al., Expression of CCR2A, an isoform of MCP-1 receptor, is increased by MCP-1, CD40 ligand and TGF-beta in fibroblast like synoviocytes of patients with RA. Exp. Mol. Med. 2007. 39: 499-507.
22. Quinones, M. P., Ahuja, S. K., Jimenez, F., Schaefer, J., Garavito, E., Rao, A., Chenaux, G. et al., Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. J. Clin. Invest. 2004. 113: 856-866.
23. Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M. and Berger, E. A., CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996. 272: 1955-1958.
24. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C. and Lusso, P., Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995. 270: 1811-1815.
25. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J. and Springer, T. A., The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996. 382: 829-833.
26. Lane, B. R., King, S. R., Bock, P. J., Strieter, R. M., Coffey, M. J. and Markovitz, D. M., The C-X-C chemokine IP-10 stimulates HIV-1 replication. Virology 2003. 307: 122-134.
27. Schmidtmayerova, H., Nottet, H. S., Nuovo, G., Raabe, T., Flanagan, C. R., Dubrovsky, L., Gendelman, H. E. et al., Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 1996. 23: 700-704.
28. Huang, Y., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S. et al., The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996. 2: 1240-1243.
29. Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J. et al., Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996. 273: 1856-1862.
30. Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. et al., Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996. 86: 367-377.
31. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C. M., Saragosti, S. et al., Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996. 382: 722-725.
32. Trumpfheller, C., Tenner-Racz, K., Racz, P., Fleischer, B. and Frosch, S., Expression of macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response. Clin. Exp. Immunol. 1998. 112: 92-99.
33. Mack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N. et al., Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J. Exp. Med. 1998. 187: 1215-1224.
34. Fatkenheuer, G., Pozniak, A. L., Johnson, M. A., Plettenberg, A., Staszewski, S., Hoepelman, A. I., Saag, M. S. et al., Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat. Med. 2005. 11: 1170-1172.
35. Mengozzi, M., De Filippi, C., Transidico, P., Biswas, P., Cota, M., Ghezzi, S., Vicenzi, E. et al., Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells. Blood 1999. 93: 1851-1857.
36. Fantuzzi, L., Canini, I., Belardelli, F. and Gessani, S., HIV-1 gp120 stimulates the production of beta-chemokines in human peripheral blood monocytes through a CD4-independent mechanism. J. Immunol. 2001. 166: 5381-5387.
37. Lehmann, M. H., Masanetz, S., Kramer, S. and Erfle, V., HIV-1 Nef upregulates CCL2/MCP-1 expression in astrocytes in a myristoylation- and calmodulin-dependent manner. J. Cell Sci. 2006. 119: 4520-4530.
38. Marini, E., Tiberio, L., Caracciolo, S., Tosti, G., Guzman, C. A., Schiaffonati, L., Fiorentini, S. et al., HIV-1 matrix protein p17 binds to monocytes and selectively stimulates MCP-1 secretion: role of transcriptional factor AP-1. Cell Microbiol. 2008. 10: 655-666.
39. Conant, K., Garzino-Demo, A., Nath, A., McArthur, J. C., Halliday, W., Power, C., Gallo, R. C. et al., Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA 1998. 95: 3117-3121.
40. Park, I. W., Wang, J. F. and Groopman, J. E., HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. Blood 2001. 97: 352-358.
41. Matsushima, K., Larsen, C. G., DuBois, G. C. and Oppenheim, J. J., Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 1989. 169: 1485-1490.
42. Cinque, P., Vago, L., Mengozzi, M., Torri, V., Ceresa, D., Vicenzi, E., Transidico, P. et al., Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. Aids 1998. 12: 1327-1332.
43. Bernasconi, S., Cinque, P., Peri, G., Sozzani, S., Crociati, A., Torri, W., Vicenzi, E. et al., Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. J. Infect. Dis. 1996. 174: 1098-1101.
44. Weiss, L., Si-Mohamed, A., Giral, P., Castiel, P., Ledur, A., Blondin, C., Kazatchkine, M. D. et al., Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1alpha and RANTES correlate with virus load in human immunodeficiency virus infection. J. Infect. Dis. 1997. 176: 1621-1624.
45. Chang, L., Ernst, T., St Hillaire, C. and Conant, K., Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients. Antivir. Ther. 2004. 9: 431-440.
46. Zink, M. C., Coleman, G. D., Mankowski, J. L., Adams, R. J., Tarwater, P. M., Fox, K. and Clements, J. E., Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J. Infect. Dis. 2001. 184: 1015-1021.
47. Floris-Moore, M., Fayad, Z. A., Berman, J. W., Mani, V., Schoenbaum, E. E., Klein, R. S., Weinshelbaum, K. B. et al., Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging. Aids 2009. 23: 941-949.
48. Bisset, L. R., Rothen, M., Joller-Jemelka, H. I., Dubs, R. W., Grob, P. J. and Opravil, M., Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir. Aids 1997. 11: 485-491.
49. Gonzalez, E., Rovin, B. H., Sen, L., Cooke, G., Dhanda, R., Mummidi, S., Kulkarni, H. et al., HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc. Natl. Acad. Sci. USA 2002. 99: 13795-13800.
50. Rovin, B. H., Lu, L. and Saxena, R., A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem. Biophys. Res. Commun. 1999. 259: 344-348.
51. Coll, B., Alonso-Villaverde, C., Parra, S., Rabassa, A., Martorell, L., Joven, J. and Masana, L., Influence of a monocyte chemoattractant protein 1 mutated allele on the response to protease inhibitor-based antiretroviral therapy. HIV Med. 2006. 7: 356-360.
52. Smith, M. W., Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Lomb, D. A., Goedert, J. J. et al., Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997. 277: 959-965.
53. Ansari, A. W., Heiken, H., Moenkemeyer, M. and Schmidt, R. E., Dichotomous effects of C-C chemokines in HIV-1 pathogenesis. Immunol. Lett. 2007. 110: 1-5.
54. Ansari, A. W., Schmidt, R. E. and Heiken, H., Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: in vivo and in vitro findings. Clin. Immunol. 2007. 125: 1-4.
55. Campbell, G. R., Watkins, J. D., Singh, K. K., Loret, E. P. and Spector, S. A., Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J. Virol. 2007. 81: 5919-5928.
56. Jourdan, P., Abbal, C., Noraz, N., Hori, T., Uchiyama, T., Vendrell, J. P., Bousquet, J. et al., IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J. Immunol. 1998. 160: 4153-4157.
57. Deeks, S. G., HIV infection, inflammation, immunosenescence, and aging. Annu. Rev. Med. 2011 62: 141-155.
58. Weiss, J. M., Nath, A., Major, E. O. and Berman, J. W., HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J. Immunol. 1999. 163: 2953-2959.
59. Sui, Y., Li, S., Pinson, D., Adany, I., Li, Z., Villinger, F., Narayan, O. et al., Simian human immunodeficiency virus-associated pneumonia correlates with increased expression of MCP-1, CXCL10, and viral RNA in the lungs of rhesus macaques. Am. J. Pathol. 2005. 166: 355-365.
60. Fisher, N. C., Neil, D. A., Williams, A. and Adams, D. H., Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease. Gut 1999. 45: 416-420.
61. Muhlbauer, M., Bosserhoff, A. K., Hartmann, A., Thasler, W. E., Weiss, T. S., Herfarth, H., Lock, G. et al., A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 2003. 125: 1085-1093.
62. 62 Gaudreault, E., Fiola, S., Olivier, M. and Gosselin, J., Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J. Virol. 2007. 81: 8016-8024.
63. Culley, F. J., Pennycook, A. M., Tregoning, J. S., Hussell, T. and Openshaw, P. J., Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J. Virol. 2006. 80: 4521-4527.
64. Yen, Y. T., Liao, F., Hsiao, C. H., Kao, C. L., Chen, Y. C. and Wu-Hsieh, B. A., Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. J. Virol. 2006. 80: 2684-2693.
65. Caruso, A., Rotola, A., Comar, M., Favilli, F., Galvan, M., Tosetti, M., Campello, C. et al., HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J. Med. Virol. 2002. 67: 528-533.
66. Kurt-Jones, E. A., Chan, M., Zhou, S., Wang, J., Reed, G., Bronson, R., Arnold, M. et al., Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA 2004. 101: 1315-1320.
67. Lee, S. K., Choi, B. K., Kang, W. J., Kim, Y. H., Park, H. Y., Kim, K. H. and Kwon, B. S., MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis. Mol. Cells 2008. 26: 67-73.
68. Cheeran, M. C., Hu, S., Yager, S. L., Gekker, G., Peterson, P. K. and Lokensgard, J. R., Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications. J. Neurovirol. 2001. 7: 135-147.
69. Stern, J. L. and Slobedman, B., Human cytomegalovirus latent infection of myeloid cells directs monocyte migration by up-regulating monocyte chemotactic protein-1. J. Immunol. 2008. 180: 6577-6585.
70. Mishra, M. K., Kumawat, K. L. and Basu, A., Japanese encephalitis virus differentially modulates the induction of multiple pro-inflammatory mediators in human astrocytoma and astroglioma cell-lines. Cell Biol. Int. 2008. 32: 1506-1513.